Type 2 & other diabetes

Two‐tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross‐sectional study

Diabetes Obes MetabPublished Cross-sectional study

Authors' conclusion

MASLD and significant liver fibrosis are common in older patients with T2DM. Fibrosis risk stratification using FIB-4, followed by VCTE, is a good strategy in real-world settings. However, relying solely on FIB-4 may fail to identify some patients with advanced disease, particularly those with increased body weight and elevated serum aminotransferase levels.

Study context

Population
Italian older outpatients with T2D who underwent vibration-controlled transient elastography (VCTE) with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) assessment
Participants
1,203 outpatients
Outcome
Prevalence and severity of MASLD (CAP ≥248 dB/m); significant liver fibrosis (LSM ≥8 kPa), cACLD (LSM ≥10 kPa), CSPH (LSM ≥25 kPa or LSM ≥20 kPa and platelet count <150 000/mm³)
Methodological detailsmulticenter, retrospective
  • Multicenter
  • Retrospective

Main finding

As reported in the abstract

Prevalence

MASLD

71.3%

Significant liver fibrosis

21.1%

Compensated advanced chronic liver disease (cACLD)

11.7%

Clinically significant portal hypertension (CSPH)

1.7%

Observational data: associations, not effects.

Further findings

Predictors of significant liver fibrosis

aOR (95% CI)
Increased body weight3.34 (1.75–6.39)
Elevated ALT levels1.54 (1.01–2.36)
OutcomeValues
FIB-4 index performance for detecting LSM≥8 kPaFIB-4 index Sensitivity 50.4% · Specificity 66.3% · NPV 83.3% · PPV 28.6%
FIB-4 index performance for detecting LSM≥8 kPa — Normal FIB-4 index with LSM <8 kPa
629 (83.3%)
FIB-4 index performance for detecting LSM≥8 kPa — Normal FIB-4 index with LSM≥8 kPa
126 (16.7%)

Original publication

Two‐tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross‐sectional study. Diabetes Obes Metab. Published 2 November 2025. doi:10.1111/dom.70245

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.